SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE)

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COMMON STOCK
Total 13F shares
77,149,796
Share change
-189,612
Total reported value
$747,565,086
Put/Call ratio
51%
Price per share
$9.69
Number of holders
198
Value change
+$1,414,796
Number of buys
92
Number of sells
96

Institutional Holders of SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) as of Q2 2021

As of 30 Jun 2021 SORRENTO THERAPEUTICS INC - COMMON STOCK (SRNE) had 198 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 77,149,796 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, JPMORGAN CHASE & CO, D. E. Shaw & Co., Inc., CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Nuveen Asset Management, LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This table shows 198 institutional shareholders of the security as of 30 Jun 2021.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.